Table 1.
Clinical and pathological characteristics in control and adjuvant TACE groups patients without risk factors for residual tumor
| Characteristics | Control | Adjuvant TACE | P value |
| (n = 174) | group (n = 77) | ||
| Gender | |||
| Female | 34 | 5 | 0.009 |
| Male | 140 | 72 | |
| Age (mean ± SD) | 50.86 ± 11.61 | 49.35 ± 10.04 | 0.323 |
| HBsAg | |||
| Positive | 43 | 11 | 0.135 |
| Negative | 131 | 66 | |
| Cirrhosis | |||
| Absent | 22 | 6 | 0.130 |
| Mild | 53 | 33 | |
| Severe | 99 | 38 | |
| Child-pugh Class | |||
| A | 165 | 77 | 0.134 |
| B | 5 | 0 | |
| AFP (mean ± SD, ug/L) | 333.91 ± 529.92 | 406.04 ± 735.16 | 0.381 |
| TNM classification | |||
| I | 28 | 19 | 0.108 |
| II | 146 | 58 |